# Deuterium Concentration as a Dual Regulator: Depletion and Enrichment Elicit Divergent Transcriptional Responses in A549 Lung Adenocarcinoma Cells

**Authors:** Gábor I. Csonka, Ildikó Somlyai, Gábor Somlyai

PMC · DOI: 10.3390/ijms27062605 · 2026-03-12

## TL;DR

Deuterium concentration affects gene expression in lung cancer cells, with depletion reducing drug resistance and enrichment increasing oncogenic activity.

## Contribution

The study reveals deuterium as a bidirectional modulator of cancer-related gene expression in A549 cells.

## Key findings

- Deuterium depletion reduces expression of multidrug resistance and signaling genes like ABCB1 and FGFR4.
- Deuterium enrichment increases oncogenic and inflammatory gene expression, including IL6 and MMP9.
- Six gene expression modules show distinct responses to deuterium levels, highlighting transcriptional vulnerabilities.

## Abstract

Deuterium abundance has been proposed as a modulator of cellular metabolism; however, its influence on cancer-associated gene expression networks remains incompletely characterized. We analyzed A549 lung adenocarcinoma cells cultured across four deuterium concentrations (40, 80, 150, and 300 ppm) using NanoString nCounter profiling. Expression data were processed through multistep filtering, symbolic trajectory encoding, and density-based spatial clustering (DBSCAN) to identify extreme expression responders, and Gaussian mixture modeling (GMM-6) to resolve coordinated gene-expression modules. DBSCAN identified 11 outlier genes under deuterium depletion, including reduced expression of multidrug-resistance–associated ABCB1 (−42% at 80 ppm), proliferative signaling component FGFR4 (−19%), and transcriptional amplifier MYCN (−24%). In contrast, enrichment at 300 ppm produced a broad increase in oncogenic expression (mean +44%), with marked elevation of inflammation-related (IL6, TGFBR2) and invasion-associated (MMP9) genes. GMM-6 clustering of the remaining core network resolved six functional modules, indicating that depletion preferentially reduces expression of genes associated with plasticity-related programs (Cluster 5: TGFB1, S100A4), while basal survival-associated genes (Cluster 6: BIRC5, RET) remain comparatively stable. Together, these results indicate that deuterium concentration acts as a bidirectional modulator of gene expression programs in the A549 model, with enrichment broadly elevating oncogenic expression and moderate depletion associated with selective downregulation of genes linked to resistance, signaling, and invasive behavior. Significance: Deuterium depletion is associated with reduced expression of genes involved in multidrug resistance, growth-factor signaling, and transcriptional amplification, revealing deuterium-responsive transcriptional vulnerabilities within the A549 lung adenocarcinoma model.

## Linked entities

- **Genes:** ABCB1 (ATP binding cassette subfamily B member 1) [NCBI Gene 5243], FGFR4 (fibroblast growth factor receptor 4) [NCBI Gene 2264], MYCN (MYCN proto-oncogene, bHLH transcription factor) [NCBI Gene 4613], IL6 (interleukin 6) [NCBI Gene 3569], TGFBR2 (transforming growth factor beta receptor 2) [NCBI Gene 7048], MMP9 (matrix metallopeptidase 9) [NCBI Gene 4318], TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040], S100A4 (S100 calcium binding protein A4) [NCBI Gene 6275], BIRC5 (baculoviral IAP repeat containing 5) [NCBI Gene 332], RET (ret proto-oncogene) [NCBI Gene 5979]
- **Diseases:** lung adenocarcinoma (MONDO:0005061)

## Full-text entities

- **Genes:** FGFR4 (fibroblast growth factor receptor 4) [NCBI Gene 2264] {aka CD334, JTK2, TKF}, TGFBR2 (transforming growth factor beta receptor 2) [NCBI Gene 7048] {aka AAT3, FAA3, LDS1B, LDS2, LDS2B, MFS2}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, MYCN (MYCN proto-oncogene, bHLH transcription factor) [NCBI Gene 4613] {aka FGLDS1, MODED, MPAPA, MYCNsORF, MYCNsPEP, N-myc}, RET (ret proto-oncogene) [NCBI Gene 5979] {aka CDHF12, CDHR16, HSCR1, MEN2A, MEN2B, MTC1}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, S100A4 (S100 calcium binding protein A4) [NCBI Gene 6275] {aka 18A2, 42A, CAPL, FSP1, MTS1, P9KA}, MMP9 (matrix metallopeptidase 9) [NCBI Gene 4318] {aka CLG4B, GELB, MANDP2, MMP-9}, ABCB1 (ATP binding cassette subfamily B member 1) [NCBI Gene 5243] {aka ABC20, CD243, CLCS, ENPAT, GP170, MDR1}, BIRC5 (baculoviral IAP repeat containing 5) [NCBI Gene 332] {aka API4, EPR-1}
- **Diseases:** cancer (MESH:D009369), inflammation (MESH:D007249)
- **Chemicals:** Deuterium (MESH:D003903)

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13027021/full.md

---
Source: https://tomesphere.com/paper/PMC13027021